skip to content »

Genetic Labs

Houston, Texas

Genetic Laboratory
Baylor Genetics Laboratories
not shown on screen

Medical Genetics Test Details

View Custom Req   |    Tests in Custom Req: 0
Search Tests: (Search by disease, test name, gene name, test code, or keyword. Return to test index.)

The American Medical Association (AMA) Current Procedural Terminology (CPT) codes and Healthcare Common Procedure Coding System (HCPCS) codes listed, are provided for informational purposes only. The codes reflect our interpretation of CPT/HCPCS coding requirements based upon AMA guidelines published annually. CPT/HCPCS codes are provided only as guidance to assist clients with billing. Baylor Genetics strongly recommends that clients confirm CPT/HCPCS codes with their Medicare Administrative Contractor (MAC) or other payer being billed, as requirements may differ. CPT coding is the sole responsibility of the billing party. Baylor Genetics assumes no responsibility for billing errors due to reliance on the CPT codes listed. Please direct any questions regarding CPT coding to the payer being billed.

Test Information: BRCA1 and BRCA2 mutations are associated with a significantly increased risk for breast, ovarian and other cancers. Approximately 25-50% of hereditary breast cancer cases have mutations in the BRCA1/2 genes. In general, this test is used when a patient's medical and family history findings strongly suggest that there is an underlying genetic etiology of breast cancer.
Test Details
Test Code: 22350
Special Notes: BRCA1 and BRCA2 gene sequencing and deletion/duplication analysis are performed via next generation sequencing.

All coding exons of these two genes and at least 20 base pairs of flanking intronic sequences are analyzed. All exonic variants and intronic variants within 20 bp of the exon/intron boundary will be reported. The NGS read depth is examined for evidence of large deletion/duplication mutations at the targeted genes. If detected, evidence of copy number change will be presented in the results and interpretation. For autosomal recessive conditions in which one mutation or at least one VUS is identified, read depth is specifically assessed.

While all regions are evaluated by NGS for possible copy number changes, variations in sample quality or the presence of pseudogenes or other homologous sequences may result in a signal to noise ratio that precludes analysis of some regions. Thus, NGS will not detect all copy number changes. A normal NGS analysis does not exclude the possibility of copy number changes of a gene or portion of a gene. Targeted Array CGH analysis is available when copy number changes are still suspected. For targeted oligonucleotide array CGH analysis: BMGL Test (#2001) for a single locus MitoMetŪPlus aCGH Analysis and Test (#2003) for multiple loci MitoMetŪPlus aCGH Analysis (Targeted Analysis) may be warranted if intragenic deletion/duplication mutations are suspected.
Technical Information
Methodology: Targeted Capture followed by Massively Parallel Sequencing
Gene Name: BRCA1 & BRCA2
Test Type: Next Generation Sequencing
Sample & Shipping Information
Test Requisition: Cancer Molecular Germline
Specimen Type: Blood
Requirements: Draw blood in an EDTA (purple-top) tube(s) and send 3-5 cc (Adults/Children).
Shipping Conditions: Ship at room temperature in an insulated container by overnight courier. Do not heat or freeze.

Specimen Type: Purified DNA
Requirements: Send at least 20ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7).
Shipping Conditions: Ship at room temperature in an insulated container by overnight courier. Do not heat or freeze.

Specimen Type: Saliva
Requirements: Collected with Oragene DNA Self-Collection Kit (provided by MGL with instruction).
Shipping Conditions: Ship at room temperature in an insulated container by overnight courier. Do not heat or freeze.

Turn Around Time: 14 days
Billing Information
List Price: *For Insurance or Institutional Prices, please call.
CPT Codes: 81162x1

Return to test index